PSI Advisors’s iShares Biotechnology ETF IBB Stock Holding History

PSI Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12	Closed	-$1.53K	–	349
2025 Q1	$1.53K	Sell	12 -19	-61%	-$2.58K	﹤0.01%	620
2024 Q4	$4.1K	Buy	31 +19	+158%	+$2.67K	﹤0.01%	647
2024 Q3	$1.75K	Hold	12	–	–	﹤0.01%	755
2024 Q2	$1.65K	Hold	12	–	–	﹤0.01%	739
2024 Q1	$1.65K	Hold	12	–	–	﹤0.01%	676
2023 Q4	$1.63K	Hold	12	–	–	﹤0.01%	731
2023 Q3	$1.47K	Hold	12	–	–	﹤0.01%	707
2023 Q2	$1.52K	Hold	12	–	–	﹤0.01%	680
2023 Q1	$1.55K	Hold	12	–	–	﹤0.01%	630
2022 Q4	$1.57K	Hold	12	–	–	﹤0.01%	626
2022 Q3	$1K	Hold	12	–	–	﹤0.01%	691
2022 Q2	$1K	Hold	12	–	–	﹤0.01%	721
2022 Q1	$2K	Hold	12	–	–	﹤0.01%	624
2021 Q4	$2K	Hold	12	–	–	﹤0.01%	667
2021 Q3	$2K	Buy	+12	New	+$2.02K	﹤0.01%	654
2020 Q1	–	Sell	-62	Closed	-$7K	–	308
2019 Q4	$7K	Buy	+62	New	+$6.92K	﹤0.01%	503

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

PSI Advisors's IBB Position: Q2 2025 in Review

PSI Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 12 shares — an estimated $1.53K sold.

PSI Advisors first reported a position in IBB in Q4 2019 and held it in 16 quarters. The position peaked at $7K in Q4 2019. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

PSI Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
PSI Advisors sold 12 iShares Biotechnology ETF shares in Q2 2025, an estimated $1.53K.
PSI Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 16 quarters.
PSI Advisors's iShares Biotechnology ETF position peaked at $7K in Q4 2019.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.